Skip to main content
. 2021 Jan 16;180(5):1581–1591. doi: 10.1007/s00431-021-03935-1

Table 3.

Summary of 13 children with MIS-C who required intensive care and second-line therapy (infliximab/a second IVIG dose) following first-line therapy with IVIG 

Age/sex/ethnicity KD-like features COVID-19 tests ECG findings ECHO findings * Anti-inflammatory treatment Supportive care Outcome/follow-up

#1

17 year Male AA

No COVID-19 PCR-positive; COVID-19 IgG-positive ECG: sinus rhythm with 1st-degree AV block, RBBB SF 12.6%, EF 26.9% Z scores: LMCA 4.2, LAD 2.77, RCA 1.87 IVIG on D#1 Infliximab on D#4 D#8 Pulse methylprednisolone 1 g IV daily × 3 Mechanical ventilation (6 days) ECMO (4 days) Vasopressors (6 days) Improved (LOS 22 days, PICU 18 days) ECHO D#77: NL anatomy and function. Z scores: LMCA 2.1, LAD 0.08, RCA 0.04

#2

14 years Female AA

No COVID-19 PCR-negative COVID-19 IgG-positive ECG: accelerated junctional rhythm, prolonged QTc SF 23.3%, EF 46.4% Z scores: LMCA 0.58, LAD − 0.41, RCA − 0.35 IVIG on D#1 Infliximab on D#2 Mechanical ventilation (4 days) Vasopressors (4 days) Improved (LOS 14 days, PICU 7 days) ECHO D#26: NL
#3 3 months Female AA Yes (classic) COVID-19 PCR-positive COVID-19 IgG-NA SF 36.1%, EF 68.3% Z scores: LMCA 2.2, LAD 3.72, RCA 0.39 IVIG on D#1 Infliximab on D#3 Improved (LOS 7 days, PICU 3 days) ECHO D#59: NL LV function. NL coronary arteries

#4

3 years Male AA

Yes (classic) COVID-19 PCR-negative COVID-19 IgG-positive SF 21%, EF 43.2% Z scores: LMCA 5.02, LAD 0.97, RCA − 0.88 IVIG on D#1 IVIG D#4 Infliximab on D#6 Vasopressors (2 days) Improved (LOS 8 days, PICU 5 days) D#80 ECHO: NL function. NL coronary arteries

#5

7 years Male South Asian

Yes (Incomplete) COVID-19 PCR-negative COVID-19 IgG-negative COVID-19-exposed ECG: PVCs and trigeminy SF 36.4%, EF 67.2% Z scores: LMCA 0.32, LAD 0.66, RCA − 0.17 IVIG on D#1 Infliximab on D#3 Improved (LOS 7 days, PICU 3 days) ECHO D#65: NL

#6

8 years Female ME

Yes (classic) COVID-19 PCR-positive COVID-19 IG-positive SF 30%, EF 58.2% Z scores: LMCA − 0.47, LAD − 0.43, RCA 0.59 IVIG on D#1 Infliximab on D#3 Vasopressors (4 days) Oxygen supplement (4 days) Improved (LOS 10 days, PICU 4 days) ECHO D#73: NL

#7

6 years Male AA

No COVID-19 PCR-negative COVID-19 IgG-positive ECG: accelerated junctional rhythm, borderline prolonged QTc SF 26%, EF 51.7% Z scores: LMCA − 0.27, LAD 0.69, RCA − 0.22 IVIG on D#1 Infliximab on D#2 Vasopressors (2 days) Oxygen supplement (2 days) Improved (LOS 5 days, PICU 2 days) ECHO D#24: NL EKG D#24: NL

#8

9 years Female AA

No COVID-19 PCR-negative COVID-19 IgG-positive SF 17.2%, EF 36.5% Z scores: LMCA − 0.47, LAD − 0.43, RCA 0.59 IVIG on D#1 Infliximab on D#2 Vasopressors (3 days) Oxygen supplement (1 days) Improved (LOS 5 days, PICU 3 days) ECH0 D#73: NL

#9

11 years Male AA

No COVID-19 PCR-negative COVID-19 IgG-positive SF 25.7%, EF 50.8% Z scores: LMCA 0.87, LAD 1.48, RCA 1.69 IVIG on D#1 Infliximab on D#3 Mechanical ventilation (5 days) Vasopressors (4 days) Improved (LOS 9 days, PICU 7 days) ECHO D#67: NL

#10

15 years Male AA

Yes (incomplete) COVID-19 PCR-positive COVID-19 IgG-positive ECG: accelerated junctional rhythm SF 8.1%, EF 17.5% Z scores: LMCA 0.32, LAD 1.17, RCA 3.18 IVIG on D#1 Infliximab on D#2 Mechanical ventilation (5 days) Vasopressors (6 days) Improved (LOS 8 days, PICU 8 days) ECHO D#164: EF 58.3%. Z score: LMCA 1.21, RCA 1.51

#11

10 years Female AA

No COVID-19 PCR-neagtive COVID-19 IgG-positive SF 24.1%, EF 48.2% Z scores: LMCA 0.32, LAD 0.63, RCA 0.51 IVIG on D#1 Infliximab on D#2 Vasopressors (6 days) Oxygen supplement (6 days) Improved (LOS 10 days, PICU 7 days) ECHO D#50: NL

#12

7 years Female AA

No COVID-19 PCR-negative COVID-19 IgG-positive SF 38.8%, EF 69.9% Z scores: LMCA − 0.46, LAD − 0.13, RCA − 0.14 IVIG on D#1 Infliximab on D#3 Improved (LOS 7 days, PICU 3 days)

#13

7 years Male AA

Yes (classic) COVID-19 PCR-negative COVID-19 IgG-positive SF 25.9%, EF 51.1% Z scores: LMCA 2.37, LAD 0.65, RCA 0.79 IVIG on D#1 IVIG on D#3 Mechanical ventilation (5 days) Vasopressors (4 days) Improved (LOS 13 days, PICU 8 days) D#45 ECHO: EF 61.6%. Z scores: LMCA 1.4. LAD − 1.7. RCA − 2.7.

MIS-C patients with dilated coronary arteries are numbered in bold IVIG intravenous immunoglobulins, D# day of PICU admission/IVIG administration, ECHO echocardiogram, SF shortening fraction, EF ejection fraction, LMCA left main coronary artery, LAD left anterior descending artery, RCA right coronary artery, ECMO extracorporeal membrane oxygenation, NL normal, LV left ventricle, RBBB right bundle branch block, PE pericardial effusion, NA not available, ECG electrocardiogram, PVC premature ventricular contraction, LOS length of hospital stay, PICU pediatric intensive care unit, AA African American, ME Middle Eastern *Significant echocardiographic findings during hospitalization; no coronary aneurysms were detected